The acting director of the US Centers for Disease Control and Prevention called for vaccine makers to develop separate shots ...
The acting director of the CDC, Jim O'Neill, in an X post on Monday called on vaccine manufacturers to develop three separate monovalent vaccines to replace the combined measles-mumps-rubella vaccine.
The CDC says on its website that “no published scientific evidence shows any benefit in separating the combination MMR vaccine into three individual shots.” ...
Individual vaccines for each virus aren't available in the U.S., and no published scientific evidence shows a benefit to ...
Advances in material science, process engineering, and application innovation will continue expanding the market, fostering ...